ArticleJournal of experimental & clinical cancer research : CR2018

Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells.

Serena Veschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.